Dr. Thomas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5115 Centre Ave
Pittsburgh, PA 15232Phone+1 412-235-1020Fax+1 412-235-1030
Summary
- Roby A. Thomas, MD, is a medical oncologist and hematologist at the University of Pittsburgh Medical Center Hillman Cancer Center. Dr. Thomas is trained in the management of all cancers and blood disorders with a focus in precision medicine for genitourinary malignancies, gastrointestinal malignancies, and benign hematology.
Dr. Thomas is board-certified in internal medicine, medical oncology and hematology. He studied chemical engineering at the University of Virginia in Charlottesville and worked as a consultant in information technology at IBM. He then changed careers ultimately completing a fellowship in Hematology/Oncology at the University of Pittsburgh, serving as the chief fellow in his final year.
His research interests include precision medicine and working with researchers from Carnegie Mellon University in the development and use of machine learning and artificial intelligence to better understand cancer. He also serves as the Assistant Director of Medical Information Systems at UPMC Hillman Cancer Center, the electronic record Medical Director for Oncology at UPMC and as a Clinical Assistant Professor of Medicine in the School of Medicine.
Dr. Thomas is a member of the American Medical Association, American Society of Hematology, and American Society of Clinical Oncology.
Education & Training
- UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2015 - 2018
- West Virginia UniversityResidency, Internal Medicine, 2012 - 2015
- American University of the Caribbean School of MedicineClass of 2012
Certifications & Licensure
- PA State Medical License Active through 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 121 citationsIntrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases.Nolan Priedigkeit, Ryan J. Hartmaier, Yijing Chen, Damir Varešlija, Ahmed Basudan
JAMA Oncology. 2017-05-01 - 4 citationsNetwork-guided prediction of aromatase inhibitor response in breast cancer.Matthew Ruffalo, Roby Antony Thomas, Jian Chen, Adrian V. Lee, Steffi Oesterreich
Plos Computational Biology. 2019-02-11 - 8 citationsTumor Size Differences Between Preoperative Endoscopic Ultrasound and Postoperative Pathology for Neoadjuvant-Treated Pancreatic Ductal Adenocarcinoma Predict Patient ...Rohit Das, Kevin McGrath, Natalie Seiser, Katelyn Smith, Shikhar Uttam
Clinical Gastroenterology and Hepatology. 2020-12-03
Press Mentions
- Researchers Develop Tool to Detect Pancreatic CystsNovember 22nd, 2022
- Microscopic Traces of Blood in Urine Linked to Urological CancerMay 12th, 2020
- Hypercalcemia in Cancer: Causes, Symptoms, and ManagementNovember 1st, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: